Yu-Waye Chu's Net Worth
$1.44 Million
Who is Yu-Waye Chu?
Yu-Waye Chu has an estimated net worth of $1.44 Million. This is based on reported shares across multiple companies, which include FATE THERAPEUTICS INC, and CytomX Therapeutics, Inc..
SEC CIK
Yu-Waye Chu's CIK is 0001854586
Past Insider Trading and Trends
2024 was Yu-Waye Chu's most active year for acquiring shares with 3 total transactions. Yu-Waye Chu's most active month to acquire stocks was the month of December. 2021 was Yu-Waye Chu's most active year for disposing of shares, totalling 11 transactions. Yu-Waye Chu's most active month to dispose stocks was the month of November. 2021 saw Yu-Waye Chu paying a total of $122,400.00 for 68,458 shares, this is the most they've acquired in one year. In 2022 Yu-Waye Chu cashed out on 8,027 shares for a total of $336,013.42, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
FATE THERAPEUTICS INC (FATE) Snapshot price: $3.41
Chief Medical OfficerYu-Waye Chu owns 140,676 units of Common stock which is worth $479,705.16.acquired a total of 101,760 shares in FATE THERAPEUTICS INC at a cost of $122,400.00, Yu-Waye also disposed a total of 29,159 shares of FATE THERAPEUTICS INC equalling to $1,052,421.02.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -1.77% | -2.53K |
$6.57 | -$16,647.66 | 140.68K |
Apr 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 6
| |||
Form 4
| -5.18% | -7.83K |
$5.24 | -$41,003.00 | 143.21K |
Jan 10
| |||
Form 4
| -2.62% | -4.06K |
$35.37 | -$143,672.94 | 151.03K |
Apr 19
| |||
Form 4
| +27.34% | 33.3K |
—
|
—
| 155.09K |
Jan 25
| |||
Form 4
| -3.15% | -3.96K |
$48.51 | -$192,340.48 | 121.79K |
Jan 11
| |||
Form 4
|
—
|
0
|
$35.05 | -$263,547.94 | 378.88K |
Scheduled
|
Dec 10
| ||
Form 4
| +94.07% | 60.96K |
—
|
—
| 125.76K |
Nov 19
| |||
Form 4
| -4.81% | -3.27K |
$83.30 | -$272,809.00 | 64.8K |
Apr 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CytomX Therapeutics, Inc. (CTMX) Snapshot price: $1.2
Chief Medical OfficerYu-Waye Chu owns 26,250 units of Common Stock which is worth $31,500.00. In the year 2023 Yu-Waye Chu acquired a total of 26,250 shares in CytomX Therapeutics, Inc..
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 26.25K |
—
|
—
| 26.25K |
Jan 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||